Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
2.220
+0.090
+(4.23%)
At close: 4:08:04 PM GMT+8
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| Chin (John F.) Director (Executive) | Other | Dec 31, 2023 | 290,496 |
| Lung (Donald Andrew J.D.) Chief Financial Officer | Other | Dec 31, 2023 | 250,000 |
| Mei (Jay M.D., Ph.D.) Chief Executive Officer | Other | Dec 31, 2023 | 1,500,000 |
| Tang (Sheng CPA) Independent Non-Executive Director | Other | Dec 31, 2023 | 25,000 |
Related Tickers
2142.HK HBM Holdings Limited
5.550
-2.80%
9995.HK RemeGen Co., Ltd.
16.460
+5.24%
6855.HK Ascentage Pharma Group International
39.750
-0.75%
6821.HK Asymchem Laboratories (Tianjin) Co., Ltd.
57.050
-1.98%
1873.HK VIVA BIOTECH
1.370
-4.86%
9969.HK InnoCare Pharma Limited
7.890
+1.68%
2616.HK CStone Pharmaceuticals
3.360
+8.39%
ASPHF Ascentage Pharma Group International
2.6900
0.00%
2509.HK Qyuns Therapeutics Co., Ltd.
6.990
-0.14%
1875.HK TOT BIOPHARM-B
1.800
-0.55%